Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15815 articles
Abnormal CA-125 levels in menopausal women without ovarian cancer.
Menopausal females with an elevated CA-125 and without ovarian cancer are exposed to an increased risk of premature mortality.
»
07/11/14
PSAT1 regulates cyclin D1 degradation and sustains proliferation of non-small cell lung cancer cells.
PSAT1 was over-expressed in NSCLC and predicted poor clinical outcome.
»
06/09/14
EGFR blockade enriches for lung cancer stem-like cells through Notch3-dependent signaling.
Kinase-dependent physical association between the Notch3 and EGFR receptors and tyrosine phosphorylation of Notch3.
»
08/16/14
Immunohistochemical evidence of association between ghrelin expression and tumor growth in esophageal carcinoma.
High ghrelin expression was observed in 61 patients (29.0%).
»
06/13/14
Coordinated expression of cyclin-dependent kinase-4 and its regulators in human oral tumors.
Coordinated up-regulation of CDK4 and its regulators takes place in oral cancer progression.
»
07/02/14
Lysyl oxidase-like 2 (LOXL2) from stromal fibroblasts stimulates the progression of gastric cancer.
LOXL2 expression in stromal cells was significantly associated with tumor invasion.
»
05/21/14
Cell division cycle-associated protein 1 overexpression is essential for the malignant potential of colorectal cancers.
CDCA1 could be a prognostic biomarker and a potential therapeutic target for CRC
»
09/04/13
Mismatch repair status and BRAF mutation status in metastatic colorectal cancer patients: a pooled analysis of the CAIRO, CAIRO2, COIN and FOCUS studies.
Poor prognosis of dMMR is driven by BRAF(MT) status.
»
08/21/14
Allogeneic DCG promote lung NK cell activation and antitumor effect after invariant NKT cell activation.
Allogeneic DCG treatment may provide a new approach in cancer immunotherapy with NKT cells.
»
07/02/14
Eph receptors as therapeutic targets in glioblastoma.
Eph targeting studies in pre-clinical models of GBM have been very encouraging.
»
12/12/13
< Prev
Next >